Nextcure, Inc.
Clinical trials sponsored by Nextcure, Inc., explained in plain language.
-
New cancer drug enters human testing for multiple advanced tumors
Disease control Recruiting nowThis is the first human study of LNCB74, a new targeted cancer drug designed to deliver chemotherapy directly to cancer cells. Researchers will test different doses in 145 adults with advanced solid tumors (including ovarian, breast, lung, and other cancers) to find the safest an…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people to test an experimental drug called SIM0505 for advanced solid tumors. It aims to find a safe dose and see early signs of whether the drug can shrink tumors. The study is for adults with specific advanced cancers, like certain ovarian, kidney, ut…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC